Ravian Pharmaceuticals Limited, a active public limited company, was established on 09 January 1996 in Patna, Bihar, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230BR1996PLC006971. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.00 M.
It upholds a compliant status. Employing 91 professional, Its leadership includes Utkarsh Singh (Director), Meenakshi Singh (Director), Rakesh Mishra (Director). Past directors included Utkarsh Singh, Meenakshi Singh, Anil Kumar Shahi. It holds ₹5.00 M open charges and ₹1.10 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ravian House, 2Nd Floor, Rajendra Ram Plaza, Exhibition Road, Patna, Bihar, 800001.
U24230BR1996PLC006971
006971
09 January 1996
₹1.00 Cr
₹9.00 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Ravian Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Utkarsh Singh | Director | 04 Jul 2021 | Current |
| Meenakshi Singh | Director | 04 Jul 2021 | Current |
| Rakesh Mishra | Director | 09 Jan 1996 | Current |
| Vijay Kumar Shahi | Managing Director | 09 Jan 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 22 Nov 2016 | Past |
| Pramod Abcsdd | Director | 30 Apr 2021 | Past |
| Pramod Abcsdd | Managing Director | 04 Jul 2021 | Past |
| Pramod Abcsdd | Director | 04 Jul 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ravian Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.54% decrease. The company also saw a substantial fall in profitability, with a 652.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ravian Pharmaceuticals had a promoter holding of 31.67% and a public holding of 68.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹1,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 1999 | Union Bank Of India | ₹5.00 M | Open |
| 05 Oct 2013 | Union Bank Of India | ₹1.10 M | Satisfied |
Explore comprehensive loan charge details -
Ravian Pharmaceuticals has a workforce of 91 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ravian Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravian Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ravian Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Ravian Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna. was documented.
Utkarsh Singh was appointed as a Director was appointed as a Director on 04 Jul 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
Meenakshi Singh was appointed as a Director was appointed as a Director on 04 Jul 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
Progress on A charge registered on 05 Oct 2013 via Charge ID 10458176 with Union Bank Of India was fully satisfied on 24 Feb 2017. was documented.
The activity A charge with Union Bank Of India amounted to Rs. 0.11 Cr with Charge ID 10458176 was registered on 05 Oct 2013. was completed.
The CIN of Ravian Pharmaceuticals Limited is U24230BR1996PLC006971.
Ravian Pharmaceuticals Limited is headquartered at Ravian House, 2Nd Floor, Rajendra Ram Plaza, Exhibition Road, Patna, Bihar, 800001.
Ravian Pharmaceuticals Limited was incorporated on 09 January 1996.
The current directors of Ravian Pharmaceuticals Limited are
The primary industry of Ravian Pharmaceuticals Limited is Trade.
Ravian Pharmaceuticals Limited is unlisted.
The authorized capital of Ravian Pharmaceuticals Limited is ₹1.00 Cr, and the paid-up capital is ₹9.00 M.
The compliance status of Ravian Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX